Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amneris E Luque

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
AIDS Care|September 4, 2020
The risk of depression among racially diverse people living with HIV: the impact of HIV viral suppressionMamta K Jain, Xilong Li, Beverley Adams-Huet, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 studyAmneris E Luque, Susan E Cohn, Jeong-Gun Park, et al.
Infectious Diseases in Obstetrics and Gynecology|July 15, 2016
Antiretroviral Resistance and Pregnancy Characteristics of Women with Perinatal and Nonperinatal HIV InfectionGweneth B Lazenby, Okeoma Mmeje, Barbra M Fisher, et al.
Therapeutic Drug Monitoring|May 6, 2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disordersQing Ma, Barry S Zingman, Amneris E Luque, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2015
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected WomenAdriana Weinberg, Jeong-Gun Park, Ronald Bosch, et al.
AIDS (London, England)|December 12, 2013
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapyJudith J Lok, Peter W Hunt, Ann C Collier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2012
Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan womenCaroline Mitchell, Jennifer E Balkus, Jennifer McKernan-Mullin, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 12, 2016
Enhancing physical function in HIV-infected older adults: A randomized controlled clinical trialKrupa N Shah, Zahraa Majeed, Yilmaz B Yoruk, et al.
Current Vascular Pharmacology|January 7, 2016
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related DisordersCindy Bednasz, Amneris E Luque, Barry S Zingman, et al.
The Journal of Infectious Diseases|February 6, 2018
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy AloneNetanya S Utay, Douglas W Kitch, Eunice Yeh, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
AIDS Care|September 4, 2020
The risk of depression among racially diverse people living with HIV: the impact of HIV viral suppressionMamta K Jain, Xilong Li, Beverley Adams-Huet, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 studyAmneris E Luque, Susan E Cohn, Jeong-Gun Park, et al.
Infectious Diseases in Obstetrics and Gynecology|July 15, 2016
Antiretroviral Resistance and Pregnancy Characteristics of Women with Perinatal and Nonperinatal HIV InfectionGweneth B Lazenby, Okeoma Mmeje, Barbra M Fisher, et al.
Therapeutic Drug Monitoring|May 6, 2011
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disordersQing Ma, Barry S Zingman, Amneris E Luque, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2015
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected WomenAdriana Weinberg, Jeong-Gun Park, Ronald Bosch, et al.
AIDS (London, England)|December 12, 2013
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapyJudith J Lok, Peter W Hunt, Ann C Collier, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 29, 2012
Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan womenCaroline Mitchell, Jennifer E Balkus, Jennifer McKernan-Mullin, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|February 12, 2016
Enhancing physical function in HIV-infected older adults: A randomized controlled clinical trialKrupa N Shah, Zahraa Majeed, Yilmaz B Yoruk, et al.
Current Vascular Pharmacology|January 7, 2016
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related DisordersCindy Bednasz, Amneris E Luque, Barry S Zingman, et al.
The Journal of Infectious Diseases|February 6, 2018
Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy AloneNetanya S Utay, Douglas W Kitch, Eunice Yeh, et al.
Pageof 3